LISTEN TO THE Plenary Speakers
Chi Udeh-Momoh
Imperial College London, UK
Chi Udeh-Momoh
Imperial College London, UK
Dr Chi Udeh-Momoh is co-Investigator, scientific coordinator and Programme Manager of several large-scale dementia prevention studies, including a world-class, single-site, epidemiological dementia-prevention programme with >2000 cognitively healthy older adults screened, and data on imaging and fluid biomarkers as well as neurocognitive and lifestyle factors collected at high throughput, alongside her role as Senior Research Associate at Bristol University. In 2018, she began developing the FINGER-AFRICA project (as co-Principal Investigator) that aims to explore the impact of multimodal lifestyle intervention strategies in Sub-Saharan African populations, and related molecular mechanisms contributing to observed effects, with European, US and African collaborators.
Andrea Bizzi
Chiesi Germany GMBH – Hamburg, Germany
Andrea Bizzi
Chiesi Germany GMBH – Hamburg, Germany
Currently Andrea Bizzi works as Managing Director with an outstanding record in delivering revenue growth and governance across EMEA and Asia-Pac through in-depth understanding of the pharmaceutical sector. Adept at developing sales-winning marketing strategies, analyzing existing and potential markets and sound knowledge of growth requirements to exceed targets and deliver brand and product objectives. Leads marketing, market access/pricing initiatives and strategies by focusing on building long-lasting relationships that are based on trust and geared for longevity. A dynamic leader with a flair for understanding customer needs and a talent for leadership, who now seeks a new challenge and utilize branding and marketing expertise to deliver financial success.
Ana Brotons-Canto
Nucaps Nanotechnology, Spain
Ana Brotons-Canto
Nucaps Nanotechnology, Spain
Ana Brotons-Canto is a R&D Manager at Nucaps Nanotechnology, Spain. She has done her PhD in Pharmacy and Master’s Degree in Drug Research, Development and Innovation. She has 9 years’ experience in nanotechnological developments.
Alain L. Fymat
Weil Institute of Critical Care Medicine, USA
Alain L. Fymat
Weil Institute of Critical Care Medicine, USA
Prof. Dr. Alain L. Fymat is a medical-physical scientist and an educator. He is the current President/ CEO and Institute Professor at the International Institute of Medicine & Science with a previous appointment as Executive Vice President/Chief Operating Officer and Professor at the Weil Institute of Critical Care Medicine, California, U.S.A. He was formerly Professor of Radiology, Radiological Sciences, Radiation Oncology, Critical Care Medicine, and Physics at several U.S. and European Universities. Earlier, he was Deputy Director (Western Region) of the U.S. Department of Veterans Affairs (Office of Research Oversight). At the Loma Linda Veterans Affairs Medical Center, he was Scientific Director of Radiology, Director of the Magnetic Resonance Imaging Center and, for a time, Acting Chair of Radiology.
Ana Brotons-Canto
Nucaps Nanotechnology, Spain
Ana Brotons-Canto
Nucaps Nanotechnology, Spain
Ana Brotons-Canto is a R&D Manager at Nucaps Nanotechnology, Spain. She has done her PhD in Pharmacy and Master’s Degree in Drug Research, Development and Innovation. She has 9 years’ experience in nanotechnological developments.
Chi Udeh-Momoh
Imperial College London, UK
Chi Udeh-Momoh
Imperial College London, UK
Dr Chi Udeh-Momoh is co-Investigator, scientific coordinator and Programme Manager of several large-scale dementia prevention studies, including a world-class, single-site, epidemiological dementia-prevention programme with >2000 cognitively healthy older adults screened, and data on imaging and fluid biomarkers as well as neurocognitive and lifestyle factors collected at high throughput, alongside her role as Senior Research Associate at Bristol University. In 2018, she began developing the FINGER-AFRICA project (as co-Principal Investigator) that aims to explore the impact of multimodal lifestyle intervention strategies in Sub-Saharan African populations, and related molecular mechanisms contributing to observed effects, with European, US and African collaborators.
Will be Updated Soon….